Mark A. Katz

8.5k total citations · 1 hit paper
75 papers, 3.1k citations indexed

About

Mark A. Katz is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Mark A. Katz has authored 75 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 35 papers in Infectious Diseases and 23 papers in Health. Recurrent topics in Mark A. Katz's work include Influenza Virus Research Studies (44 papers), Respiratory viral infections research (26 papers) and Vaccine Coverage and Hesitancy (23 papers). Mark A. Katz is often cited by papers focused on Influenza Virus Research Studies (44 papers), Respiratory viral infections research (26 papers) and Vaccine Coverage and Hesitancy (23 papers). Mark A. Katz collaborates with scholars based in United States, Kenya and Israel. Mark A. Katz's co-authors include Marc Lipsitch, Miguel A. Hernán, Noam Barda, Oren Miron, Ben Y. Reis, Eldad Kepten, Ran D. Balicer, Noa Dagan, Robert F. Breiman and Gideon O. Emukule and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Mark A. Katz

74 papers receiving 3.0k citations

Hit Papers

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vacci... 2021 2026 2022 2024 2021 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Katz United States 22 1.7k 967 840 553 379 75 3.1k
Kathleen Dooling United States 26 1.4k 0.8× 1.5k 1.6× 1.1k 1.3× 382 0.7× 185 0.5× 66 3.6k
Bradley K. Ackerson United States 26 2.1k 1.3× 1.1k 1.2× 929 1.1× 396 0.7× 222 0.6× 100 3.4k
Jim McMenamin United Kingdom 34 1.6k 0.9× 2.3k 2.4× 755 0.9× 639 1.2× 120 0.3× 109 4.0k
Tyra Grove Krause Denmark 28 847 0.5× 1.1k 1.1× 648 0.8× 297 0.5× 138 0.4× 100 2.5k
Marta Luisa Ciofi degli Atti Italy 35 787 0.5× 2.4k 2.5× 626 0.7× 292 0.5× 423 1.1× 183 4.0k
Sarah A. Buchan Canada 25 1.3k 0.8× 655 0.7× 504 0.6× 307 0.6× 91 0.2× 94 2.1k
Young June Choe South Korea 25 830 0.5× 764 0.8× 431 0.5× 247 0.4× 137 0.4× 197 2.0k
Lina S. Sy United States 30 1.1k 0.7× 2.3k 2.4× 669 0.8× 139 0.3× 236 0.6× 124 3.6k
Stefano Tempia South Africa 32 1.0k 0.6× 2.6k 2.7× 421 0.5× 367 0.7× 129 0.3× 166 3.4k
Debra Blog United States 18 1.8k 1.1× 1.1k 1.2× 440 0.5× 112 0.2× 711 1.9× 41 3.1k

Countries citing papers authored by Mark A. Katz

Since Specialization
Citations

This map shows the geographic impact of Mark A. Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Katz more than expected).

Fields of papers citing papers by Mark A. Katz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Katz. The network helps show where Mark A. Katz may publish in the future.

Co-authorship network of co-authors of Mark A. Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Katz. A scholar is included among the top collaborators of Mark A. Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Katz. Mark A. Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Juntao, et al.. (2025). RNA-mediated CRISPR-Cas13 inhibition through crRNA structural mimicry. Science. 388(6745). 387–391. 1 indexed citations
3.
Cohuet, Sandra, Naser Ramadani, Kostas Danis, et al.. (2025). COVID‐19 Vaccine Effectiveness Against Hospitalizations and Severe Outcomes in Kosovo, 2022–2024: A Test‐Negative Case–Control Study. Influenza and Other Respiratory Viruses. 19(9). e70152–e70152. 1 indexed citations
4.
Fowlkes, Ashley, Alon Peretz, David Greenberg, et al.. (2024). Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel. International Journal of Infectious Diseases. 149. 107260–107260. 1 indexed citations
5.
Katz, Mark A., Michael Herdman, Barbara Mühlemann, et al.. (2023). The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021. Influenza and Other Respiratory Viruses. 17(10). e13147–e13147. 2 indexed citations
6.
Eisenberg, Marisa C., et al.. (2023). Racial and ethnic disparities in access to safe water and sanitation in high-income countries: a case study among the Arab-Bedouins of Southern Israel. Journal of Water Sanitation and Hygiene for Development. 13(9). 611–624. 2 indexed citations
7.
Kissling, Esther, Julia Rubin-Smith, Marta Valenciano, et al.. (2022). COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data. BMJ Open. 12(3). e057741–e057741. 5 indexed citations
8.
Gon, Giorgia, et al.. (2022). Factors associated with early uptake of COVID‐19 vaccination among healthcare workers in Azerbaijan, 2021. Influenza and Other Respiratory Viruses. 16(4). 626–631. 10 indexed citations
9.
Irving, Stephanie A., Sarah Ball, Annette K. Regan, et al.. (2021). A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010–2016. Vaccine. 39(52). 7598–7605. 7 indexed citations
10.
Dagan, Noa, Noam Barda, Eldad Kepten, et al.. (2021). BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. New England Journal of Medicine. 384(15). 1412–1423. 1619 indexed citations breakdown →
11.
Schaad, Nicolas, Eyal Leshem, Ikwo Oboho, et al.. (2015). Hospitalizations and Deaths Because of Respiratory and Diarrheal Diseases Among Haitian Children Under Five Years of Age, 2011–2013. The Pediatric Infectious Disease Journal. 34(10). e238–e243. 17 indexed citations
12.
Muñoz, Flor M., Linda O. Eckert, Mark A. Katz, et al.. (2015). Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions. Vaccine. 33(47). 6441–6452. 30 indexed citations
13.
Emukule, Gideon O., Sammy Khagayi, Meredith McMorrow, et al.. (2014). The Burden of Influenza and RSV among Inpatients and Outpatients in Rural Western Kenya, 2009–2012. PLoS ONE. 9(8). e105543–e105543. 69 indexed citations
14.
Njuguna, Henry, Jamal Ahmed, Prisca A. Oria, et al.. (2013). Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010. Vaccine. 31(41). 4662–4667. 11 indexed citations
15.
Fuller, James A., Aimee Summers, Mark A. Katz, et al.. (2013). Estimation of the National Disease Burden of Influenza-Associated Severe Acute Respiratory Illness in Kenya and Guatemala: A Novel Methodology. PLoS ONE. 8(2). e56882–e56882. 34 indexed citations
16.
Munyua, Peninah, Jane Githinji, Lilian W. Waiboci, et al.. (2012). Detection of influenza A virus in live bird markets in Kenya, 2009–2011. Influenza and Other Respiratory Viruses. 7(2). 113–119. 15 indexed citations
17.
Fitter, David L., Josiane Buteau, Roc Magloire, et al.. (2012). Pandemic H1N1 influenza surveillance in Haiti, July–December 2009. Influenza and Other Respiratory Viruses. 7(5). 772–775. 1 indexed citations
18.
Mmbaga, Vida, et al.. (2012). Results From the First 30 Months of National Sentinel Surveillance for Influenza in Tanzania, 2008–2010. The Journal of Infectious Diseases. 206(suppl_1). S80–S86. 20 indexed citations
19.
Katz, Mark A., Mark J. Lamias, David K. Shay, & Timothy M. Uyeki. (2009). Use of rapid tests and antiviral medications for influenza among primary care providers in the United States. Influenza and Other Respiratory Viruses. 3(1). 29–35. 14 indexed citations
20.
Ortiz, Justin R., Mark A. Katz, Eileen C. Farnon, et al.. (2007). Lack of Evidence of Avian‐to‐Human Transmission of Avian Influenza A (H5N1) Virus among Poultry Workers, Kano, Nigeria, 2006. The Journal of Infectious Diseases. 196(11). 1685–1691. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026